The role of major allergens Art v 1 and Art v 3 in Artemisia pollen-induced asthma: a mouse model study
Akhtemova N. Sergazina A. Bolatbekov T. Rakhmatullayeva G. Tailakova E. Tabynov K. Fomin G. Zhao L. Gao Z. Tabynov K.
2025Frontiers Media SA
Frontiers in Immunology
2025#16
Background: Artemisia pollen is a major airborne allergen contributing to seasonal allergic rhinitis and bronchial asthma worldwide. However, the specific allergenic potential of different Artemisia species and their major allergens, Art v 1 and Art v 3, remains poorly understood. Methods: This study utilized a BALB/c mouse model to comparatively assess the allergenic potential of A. vulgaris, A. absinthium, and A. annua. Mice were sensitized and challenged with standardized pollen extracts, and allergic responses were evaluated through serum IgE levels, airway hyperreactivity, ear swelling, and histopathological lung analysis. The correlation between allergen content (Art v 1 and Art v 3) and allergic outcomes was also examined. Results: A. vulgaris exhibited the highest allergenicity, inducing the most pronounced IgE response, airway hyperresponsiveness, and severe pulmonary pathology. A. absinthium displayed intermediate allergenic potential, while A. annua elicited the mildest allergic response. Art v 1 levels strongly correlated with key clinical and pathological markers of asthma, whereas Art v 3 showed no significant association. Notably, the Art v 1/Art v 3 ratio emerged as the strongest predictor of pulmonary pathology. Conclusion: These findings establish Art v 1 as the key driver of Artemisia-induced allergic inflammation and emphasize its dominance over Art v 3 in pollen as a critical factor in the development of allergic lung pathology. These findings provide new insights into the molecular basis of Artemisia pollen allergy and may inform future diagnostic and therapeutic strategies. Copyright
allergic asthma , Art v 1 , Art v 3 , Artemisia pollen , mouse model , pulmonary pathology
Text of the article Перейти на текст статьи
International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan
Preclinical Research Laboratory with Vivarium, M. Aikimbayev National Research Center for Especially Dangerous Infections, Almaty, Kazakhstan
T&TvaX LLC, Almaty, Kazakhstan
College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, China
Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, China
Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
Republican Allergy Center, Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan
International Center for Vaccinology
Preclinical Research Laboratory with Vivarium
T&TvaX LLC
College of Agriculture and Biotechnology
Institute of Immunology
Department of Allergy
Republican Allergy Center
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026